Results 81 to 90 of about 40,749 (237)

An overview of insulin therapy for the non‐specialist

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Nearly all health professionals, whatever their practice or speciality, now have contact with a significant number of insulin‐using people with diabetes. People with type 1 diabetes are nearly universally managed on more complex insulin regimens, increasingly with complex support technology, and with some understanding of the concepts ...
Philip D. Home
wiley   +1 more source

A dark and black esophagus

open access: yesEmergency Care Journal
A 70-year-old Italian man presented to our emergency department for dyspnea and confusion. He was affected by diabetes mellitus type 2, but he stopped his medication 10 years before.
Flavio Scarilli, Davide Tizzani
doaj   +1 more source

Practical considerations for using the Omnipod® 5 Automated Insulin Delivery System: Clinical experience from the United States and Europe

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Automated insulin delivery (AID) systems, which consist of an insulin pump, a continuous glucose monitoring system and a software algorithm to automate insulin delivery based on real time glycaemic data, are rapidly evolving. AID is now strongly recommended as the insulin delivery method of choice for people with type 1 diabetes.
Cari Berget   +7 more
wiley   +1 more source

Starvation ketoacidosis on the acute medical take: an easily missed complication of the keto diet

open access: yesEuropean Journal of Case Reports in Internal Medicine
Starvation ketoacidosis represents one of the three forms of metabolic acidosis caused by the accumulation of ketone bodies within the blood stream. It can be easily missed in patients who present acutely and are found to have an unexplained or profound ...
Ayesha Shaikh   +3 more
doaj   +1 more source

Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin‐deficient phenotype: A real world analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Diabetic kidney disease (DKD) is a major complication of diabetes, including in insulin‐deficient phenotypes, yet data on kidney outcomes with sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in this population are limited. This study investigates the impact of SGLT2i on kidney outcomes in patients with insulin‐deficient diabetes using ...
Anat Tsur   +3 more
wiley   +1 more source

Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Glycaemic therapy in type 1 diabetes (T1D) is focused on insulin, with the majority of studies investigating different insulin preparations, delivery devices and dosing accuracy methods. While insulin deficiency is the key mechanism for hyperglycaemia in T1D, individuals with this condition can also develop insulin resistance (IR), making ...
Ahmad M. Rajab   +2 more
wiley   +1 more source

Snap diagnosis of fulminant type 1 diabetes by the normalized glucose/HbA1c ratio

open access: yesEndocrine Journal
Elevated Fulminant Index (FI), [plasma glucose (PG)/glycosylated hemoglobin A1c (HbA1c)], was reportedly a sensitive index to differentiate fulminant type 1 diabetes (FT1D) from non-fulminant T1D (nFT1D).
Jun-Ichiro Mori   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy